Search Results 1251-1260 of 27640 for female

  1. Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

    Male or female patients, ≥18 years of age at the time of informed consent. · Histologic diagnosis of GIST. · Patients must have progressed on imatinib, sunitinib ...

  2. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: BPA linked to immune cell activation in female mice. Dana Sparks. September 28, 2019. New therapies bring hope for ovarian cancer featured ...

  3. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: BPA linked to immune cell activation in female mice. Dana Sparks. October 12, 2019. Research. Let's focus on the problem: Purposeful shared ...

  4. Study of Immunotherapy and Ovarian Function Among Premenopausal Melanoma Survivors - Mayo Clinic

    The purpose of this study is to analyze the ovary function of female premenopausal melanoma survivors who have undergone immunotherapy, and to compare with data ...

  5. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    All females of childbearing potential must have a blood test or urine study within 2 weeks prior to registration to rule out pregnancy. A female of ...

  6. Female aged 21-65 years who reported being up-to-date with cervical cancer. State. Prostate. 109.6. 16.5 screening. Lung & Bronchus. 57.9. 32.4. Target. 86.3%.

  7. Pseudotumor cerebri (idiopathic intracranial hypertension) - Diagnosis & treatment - Mayo Clinic

    Addison's disease presenting with idiopathic intracranial hypertension in a young female. Cureus. 2021; doi:10.7759/cureus.15195. Meagan S, et al ...

  8. The role of lifestyle-related treatments for IBS - Mayo Clinic

    Irritable bowel syndrome and female patients. Gastroenterology Clinics of North America. 2016;45:179. Lucak S, et al. Current and emergent pharmacologic ...

  9. Female aged 21-65 years who reported being up-to-date with cervical cancer screening. State. Lung & Bronchus. 67.7. 41.2. Target. 84.0%. 77.5%. 84.3%. Colon & ...

  10. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

    Females of childbearing potential must also agree to ongoing pregnancy testing while on protocol treatment. A female of childbearing potential is defined as ...